1. Home
  2. IMAB vs DVS Comparison

IMAB vs DVS Comparison

Compare IMAB & DVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • DVS
  • Stock Information
  • Founded
  • IMAB 2014
  • DVS 2011
  • Country
  • IMAB United States
  • DVS Canada
  • Employees
  • IMAB N/A
  • DVS N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • DVS
  • Sector
  • IMAB Health Care
  • DVS
  • Exchange
  • IMAB Nasdaq
  • DVS Nasdaq
  • Market Cap
  • IMAB 486.4M
  • DVS 401.8M
  • IPO Year
  • IMAB 2020
  • DVS N/A
  • Fundamental
  • Price
  • IMAB $4.70
  • DVS $4.11
  • Analyst Decision
  • IMAB Strong Buy
  • DVS
  • Analyst Count
  • IMAB 6
  • DVS 0
  • Target Price
  • IMAB $7.50
  • DVS N/A
  • AVG Volume (30 Days)
  • IMAB 2.2M
  • DVS 1.1M
  • Earning Date
  • IMAB 11-14-2025
  • DVS 11-23-2025
  • Dividend Yield
  • IMAB N/A
  • DVS N/A
  • EPS Growth
  • IMAB N/A
  • DVS N/A
  • EPS
  • IMAB N/A
  • DVS N/A
  • Revenue
  • IMAB N/A
  • DVS N/A
  • Revenue This Year
  • IMAB N/A
  • DVS N/A
  • Revenue Next Year
  • IMAB N/A
  • DVS N/A
  • P/E Ratio
  • IMAB N/A
  • DVS N/A
  • Revenue Growth
  • IMAB N/A
  • DVS N/A
  • 52 Week Low
  • IMAB $0.60
  • DVS $2.48
  • 52 Week High
  • IMAB $6.79
  • DVS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 49.60
  • DVS 42.76
  • Support Level
  • IMAB $4.13
  • DVS $4.07
  • Resistance Level
  • IMAB $6.79
  • DVS $4.43
  • Average True Range (ATR)
  • IMAB 0.72
  • DVS 0.26
  • MACD
  • IMAB -0.14
  • DVS -0.09
  • Stochastic Oscillator
  • IMAB 21.43
  • DVS 12.50

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About DVS Dolly Varden Silver Corporation Common Shares

Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.

Share on Social Networks: